Lu‐Nan Qi

1.1k total citations
41 papers, 742 citations indexed

About

Lu‐Nan Qi is a scholar working on Hepatology, Oncology and Epidemiology. According to data from OpenAlex, Lu‐Nan Qi has authored 41 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 20 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Lu‐Nan Qi's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Lu‐Nan Qi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Lu‐Nan Qi collaborates with scholars based in China, Brunei and United States. Lu‐Nan Qi's co-authors include Bang‐De Xiang, Liang Ma, Feixiang Wu, Jian‐Hong Zhong, Zu-Shun Chen, Ze‐Guang Han, Le‐Qun Li, Wen‐Feng Gong, Yuanyuan Chen and Jiazhou Ye and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Lu‐Nan Qi

39 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu‐Nan Qi China	12	287	284	266	178	172	41	742
Benjamin Ruf United States	14	146 0.5×	343 1.2×	146 0.5×	280 1.6×	192 1.1×	29	869
Teruyuki Ueda Japan	10	328 1.1×	182 0.6×	286 1.1×	350 2.0×	226 1.3×	21	830
Mengya Zang China	11	199 0.7×	161 0.6×	66 0.2×	94 0.5×	109 0.6×	25	509
Oksana Kowalczuk Poland	15	87 0.3×	172 0.6×	136 0.5×	215 1.2×	131 0.8×	51	720
Joaquim Moreno‐Càceres Spain	8	279 1.0×	132 0.5×	104 0.4×	297 1.7×	222 1.3×	8	669
Pingping Xu China	16	66 0.2×	269 0.9×	140 0.5×	237 1.3×	43 0.3×	51	619
Akihiro Seki Japan	13	158 0.6×	250 0.9×	49 0.2×	227 1.3×	155 0.9×	41	801
Benjamin C. Yan United States	13	67 0.2×	100 0.4×	103 0.4×	236 1.3×	82 0.5×	19	535
Yasushi Yamaguchi Japan	19	127 0.4×	357 1.3×	124 0.5×	226 1.3×	127 0.7×	35	768
Yu-Chih Wu Taiwan	13	119 0.4×	146 0.5×	198 0.7×	355 2.0×	103 0.6×	23	757

Countries citing papers authored by Lu‐Nan Qi

Since Specialization

Citations

This map shows the geographic impact of Lu‐Nan Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Nan Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Nan Qi more than expected).

Fields of papers citing papers by Lu‐Nan Qi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu‐Nan Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Nan Qi. The network helps show where Lu‐Nan Qi may publish in the future.

Co-authorship network of co-authors of Lu‐Nan Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Nan Qi. A scholar is included among the top collaborators of Lu‐Nan Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Nan Qi. Lu‐Nan Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Jing‐Xuan, Yuanyuan Chen, Lu‐Nan Qi, & Yuchong Peng. (2024). Investigation of the causal relationship between breast cancer and thyroid cancer: a set of two-sample bidirectional Mendelian randomization study. Endocrine. 87(1). 196–205. 1 indexed citations

Zhan, Lu, et al.. (2023). High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells. Journal of Hepatocellular Carcinoma. Volume 10. 57–68. 4 indexed citations

Zhan, Lu, et al.. (2023). Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy. BMC Cancer. 23(1). 1150–1150. 4 indexed citations

Li, Jianrong, Jinming Wang, Wei Tian, et al.. (2023). Importance of optimizing duration of adjuvant immune checkpoint inhibitor therapy to treat postoperative hepatocellular carcinoma after conversion therapy: a case report. Journal of Surgical Case Reports. 2023(11). rjad610–rjad610. 2 indexed citations

Xu, Jing‐Xuan, et al.. (2023). Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors. Cancer Medicine. 12(14). 15065–15078. 6 indexed citations

Zhong, Jian‐Hong, et al.. (2023). A retrospective study exploring the safety and efficacy of hepatic arterial infusion chemotherapy and sequential transarterial embolization combined with lenvatinib and tislelizumab in unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. 41(16_suppl). e16219–e16219.

Yang, Xihua, Lu Zhan, Jie Zhang, et al.. (2023). Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma. BMC Cancer. 23(1). 10–10. 12 indexed citations

Peng, Yuchong, et al.. (2022). Integrated omics analysis: the relationship between significantly increased Klebsiella post-hepatectomy and decreased hub-metabolite 3-methyl-2-oxobutanoic acid is associated with induced liver failure. Journal of Gastrointestinal Oncology. 13(1). 326–343. 5 indexed citations

Peng, Yuchong, et al.. (2022). Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure. Annals of Translational Medicine. 10(10). 549–549. 10 indexed citations

10.

Qi, Lu‐Nan, Yingchun Liu, Xianguo Zhou, et al.. (2021). Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis. Journal of Cancer. 12(15). 4455–4462. 12 indexed citations

11.

Bai, Tao, Rongyun Mai, Jie Chen, et al.. (2020). Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma. Translational Cancer Research. 9(3). 1384–1394. 9 indexed citations

12.

Ma, Liang, et al.. (2019). Comparison of the effect on the prognosis of HCC in terms of different surgical approaches for hepatic inflow occlusion. Translational Cancer Research. 8(4). 1506–1516.

13.

Qi, Lu‐Nan, Bang‐De Xiang, Feixiang Wu, et al.. (2018). Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Cancer Research. 78(16). 4731–4744. 226 indexed citations

14.

Chen, Zu-Shun, Shao‐Liang Zhu, Lu‐Nan Qi, & Le‐Qun Li. (2018). A combination of subcuticular suture and enhanced recovery after surgery reduces wound complications in patients undergoing hepatectomy for hepatocellular carcinoma. Scientific Reports. 8(1). 12942–12942. 4 indexed citations

15.

Wu, Feixiang, Jie Chen, Tao Bai, et al.. (2017). The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma. BMC Cancer. 17(1). 645–645. 42 indexed citations

16.

Ye, Jiazhou, Zhibo Xie, Tao Bai, et al.. (2016). Postoperative adjuvant transarterial chemoembolization after curative resection reduces early recurrence of hepatocellular carcinoma. Zhonghua gan-dan waike zazhi. 22(4). 217–222. 1 indexed citations

17.

Chen, Zu-Shun, Shao‐Liang Zhu, Lu‐Nan Qi, & Le‐Qun Li. (2016). Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy. OncoTargets and Therapy. Volume 9. 4129–4135. 10 indexed citations

18.

Liu, Lei, Qishun Zhang, Linghui Pan, et al.. (2015). Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study. Tumor Biology. 37(4). 5327–5335. 7 indexed citations

19.

Qi, Lu‐Nan, Le‐Qun Li, Yuanyuan Chen, et al.. (2013). Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China. PLoS ONE. 8(12). e83465–e83465. 35 indexed citations

20.

Li, Le‐Qun, Xiao Qin, Tao Peng, et al.. (2011). Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus. Annals of Surgical Oncology. 18(5). 1258–1266. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact